Glucagon stimulation test with a peak GH level less than or equal to 3.0 ng/mL in members with a body mass index (BMI) less than or equal to 30 kg/m2and a high pretest probability of GHD (e.g., acquired structural abnormalities) or a BMI less than 25 kg/m2; Glucagon stimulation te...
The aim of the present review is to describe the current knowledge on GST.#Narrative review.#In the last years several studies have suggested some changes in the original GST protocol and have questioned its diagnostic accuracy when the classic GH cut-point of 3 渭g/L is used, suggesting ...
H (-1.91 / -2.93 SDS, M -2.59) and HV (-0.06 / -3.50 SDS, M -1.81) treated with the same protocol. H and HV significantly increased after both 6 and 12 m of GH therapy (p<0.02) without any significant change in BA / CA ratio ( Wilcoxon and Mann-Whitney tests). No ...
cDNA was prepared using a Superscript III First-strand synthesis system, oligo-dT primers and 5 µg of DNase-treated RNA following the manufacturer’s protocol (Life Technologies, Carlsbad, USA). Gene-specific primers for each GH family homolog (Additional file 1: Table S2a) were designed ...
Protocol Participants attended two test sessions on consecutive days. On both study days, after an overnight fast, a forearm i.v. catheter was inserted at 0845. At 0902, 100 μg ghrelin (Clinalfa, Läufelfingen, Switzerland) or placebo (saline infusion) was injected as a single i.v...
Materials and methods A total of 115 obese patients (BMI> 30) were enrolled in the protocol (65 patients with liver steatosis and 50 age- and BMI-matched controls). In all patients, the following parameters were studied: serum levels of glucose, insulin, the HOMA index, IGF-I, GHBP,...